146 related articles for article (PubMed ID: 37599063)
1. Adjuvant and neoadjuvant chemotherapy for biliary tract cancer: a review of randomized controlled trials.
Nakachi K; Gotohda N; Hatano E; Nara S; Takahashi S; Kawamoto Y; Ueno M
Jpn J Clin Oncol; 2023 Nov; 53(11):1019-1026. PubMed ID: 37599063
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials.
Nara S; Esaki M; Ban D; Takamoto T; Shimada K; Ioka T; Okusaka T; Ishii H; Furuse J
Jpn J Clin Oncol; 2020 Dec; 50(12):1353-1363. PubMed ID: 33037430
[TBL] [Abstract][Full Text] [Related]
3. Capecitabine Extends Survival for Biliary Tract Cancer.
Cancer Discov; 2017 Jul; 7(7):OF1. PubMed ID: 28572460
[TBL] [Abstract][Full Text] [Related]
4. Role of adjuvant and neoadjuvant therapy for resectable biliary tract cancer.
Nara S; Esaki M; Ban D; Takamoto T; Mizui T; Shimada K
Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):537-545. PubMed ID: 33793366
[No Abstract] [Full Text] [Related]
5. Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials.
Belkouz A; Wilmink JW; Haj Mohammad N; Hagendoorn J; de Vos-Geelen J; Dejong CHC; Homs MYV; Groot Koerkamp B; van Gulik TM; van Oijen MGH; Punt CJA; Klümpen H
Crit Rev Oncol Hematol; 2020 Jul; 151():102975. PubMed ID: 32464483
[TBL] [Abstract][Full Text] [Related]
6. The Landmark Series: Gallbladder Cancer.
Gamboa AC; Maithel SK
Ann Surg Oncol; 2020 Aug; 27(8):2846-2858. PubMed ID: 32474816
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy in biliary tract cancer: state of the art and future perspectives.
Akhoundova Sanoyan D; McNamara MG; Lamarca A; Valle JW
Curr Opin Oncol; 2020 Jul; 32(4):364-369. PubMed ID: 32541326
[TBL] [Abstract][Full Text] [Related]
8. BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care.
Rizzo A; Brandi G
Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):483-485. PubMed ID: 33307876
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy for resectable biliary tract cancer: current status and future direction.
Konishi M
J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):301-5. PubMed ID: 22262202
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
Abdel-Rahman O; Elsayed Z; Elhalawani H
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
[TBL] [Abstract][Full Text] [Related]
11. ADJUBIL: phase II study of adjuvant immunotherapy with STRIDE regimen with/without capecitabine in biliary tract cancers.
Goetze T; Gonzalez-Carmona MA; Kochen L; Agaoglu NB; Al-Batran SE; Habibzada T; Pons M; Brunner M; Ettrich TJ; Köhne CH; Roderburg C; Modest D
Future Oncol; 2024 Feb; 20(6):307-315. PubMed ID: 38410920
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy in biliary tract cancer patients: A systematic review and meta-analysis of randomized controlled trials.
Caparica R; Bruzzone M; Hachem GE; Ceppi M; Lambertini M; Glasberg J; de Azambuja E; Van Laethem JL; Hendlisz A
Crit Rev Oncol Hematol; 2020 May; 149():102940. PubMed ID: 32252001
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline.
Shroff RT; Kennedy EB; Bachini M; Bekaii-Saab T; Crane C; Edeline J; El-Khoueiry A; Feng M; Katz MHG; Primrose J; Soares HP; Valle J; Maithel SK
J Clin Oncol; 2019 Apr; 37(12):1015-1027. PubMed ID: 30856044
[TBL] [Abstract][Full Text] [Related]
14. Role of chemotherapy in treatments for biliary tract cancer.
Furuse J; Kasuga A; Takasu A; Kitamura H; Nagashima F
J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):337-41. PubMed ID: 22456744
[TBL] [Abstract][Full Text] [Related]
15. Capecitabine: Still a Standard Option in the Adjuvant Setting of Biliary Tract Cancer?
Edeline J; Malka D
J Clin Oncol; 2022 Nov; 40(31):3667-3668. PubMed ID: 35786978
[No Abstract] [Full Text] [Related]
16. Postoperative adjuvant treatments for biliary tract cancer.
Furuse J
J Hepatobiliary Pancreat Surg; 2008; 15(5):463-7. PubMed ID: 18836797
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant treatments in biliary tract cancer: an analysis based on restricted mean survival time.
Messori A; Bartoli L; Trippoli S
Dig Liver Dis; 2020 Oct; 52(10):1208-1209. PubMed ID: 32505564
[No Abstract] [Full Text] [Related]
18. Overview of adjuvant and neoadjuvant therapy for resectable gastric cancer in the East.
Fujitani K
Dig Surg; 2013; 30(2):119-29. PubMed ID: 23867588
[TBL] [Abstract][Full Text] [Related]
19. Oral versus intravenous fluoropyrimidines for colorectal cancer.
Chionh F; Lau D; Yeung Y; Price T; Tebbutt N
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD008398. PubMed ID: 28752564
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of S-1 adjuvant chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202.
Kobayashi S; Nakachi K; Ikeda M; Konishi M; Ogawa G; Sugiura T; Yanagimoto H; Morinaga S; Wada H; Shimada K; Takahashi Y; Nakagohri T; Kamata K; Shimizu Y; Ajiki T; Hirano S; Gotohda N; Ueno M; Okusaka T; Furuse J
Eur J Surg Oncol; 2024 Feb; 50(2):107324. PubMed ID: 38157649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
